NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $55,196 | -29.2% | 24,423 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $78,000 | -25.0% | 24,423 | -10.9% | 0.01% | -28.6% |
| Q2 2022 | $104,000 | +38.7% | 27,412 | +97.1% | 0.01% | +40.0% |
| Q1 2022 | $75,000 | -88.0% | 13,906 | -59.5% | 0.01% | -78.3% |
| Q3 2019 | $626,000 | -11.3% | 34,367 | +73.3% | 0.05% | -17.9% |
| Q2 2019 | $706,000 | +6.0% | 19,834 | 0.0% | 0.06% | -11.1% |
| Q1 2019 | $666,000 | -2.9% | 19,834 | -5.0% | 0.06% | +12.5% |
| Q4 2018 | $686,000 | +259.2% | 20,878 | +34.0% | 0.06% | +194.7% |
| Q1 2017 | $191,000 | 0.0% | 15,584 | 0.0% | 0.02% | -26.9% |
| Q4 2016 | $191,000 | – | 15,584 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |